In the current study, MGP was rarely expressed in lung adenocarcinomas (0.7%), which is lower than the previously reported positivity of GATA3 (∽8%, [7, 69]) and TRPS1 (2–3%, [31, 37]), indicating that MGP is a good marker to differentiate breast cancer from lung adenocarcinoma. This evidence concerns the gene GATA3 and breast carcinoma.